Resin et al., 1973 - Google Patents
Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in manResin et al., 1973
- Document ID
- 5049880562698668484
- Author
- Resin H
- Stern D
- Sturdevant R
- Isenberg J
- Publication year
- Publication venue
- Gastroenterology
External Links
Snippet
Graded doses of synthetic C-terminal octapeptide of cholecystokinin, injected intravenously, produced graded decreases in lower esophageal sphincter pressure in man. The calculated maximal decrease which could be produced by the octapeptide of cholecystokinin was 60 …
- 210000000111 Esophageal Sphincter, Lower 0 title abstract description 45
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Resin et al. | Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in man | |
| US5574010A (en) | Treatment of pancreatic tumors with peptide YY and analogs thereof | |
| Vagne et al. | Cholecystokinetic potency of gastrointestinal hormones and related peptides | |
| Johnson et al. | Analysis of inhibition of acid secretion by cholecystokinin in dogs | |
| KR20240060873A (en) | Gip/glp1 agonist compositions | |
| Fiorucci et al. | Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways | |
| Harding et al. | Inability of [125I] Sar1, Ile8‐angiotensin II to move between the blood and cerebrospinal fluid compartments | |
| Bertaccini et al. | Cholecystokinetic activity of the new peptide caerulein in man | |
| Liu et al. | Effect of tumor necrosis factor on hypoxic pulmonary vasoconstriction | |
| Okuno et al. | SQ 14, 225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries | |
| EIDE | Renovascular hypertension in rats immunized with angiotensin II | |
| US5411943A (en) | Hepatoma treatment with somatostatin analogs | |
| OIZUMI et al. | Pharmacological profiles of CS-622, a novel angiotensin converting enzyme inhibitor | |
| Garcia et al. | Effect of a recombinant endotoxin-neutralizing protein on endotoxin shock in rabbits | |
| Bassotti et al. | Double-blind, placebo-controlled study on effects of diclofenac sodium and indomethacin on postprandial gastric motility in man | |
| Schofield et al. | Leucopenia and fever in the" Jarisch-Herxheimer" reaction of louse-borne relapsing fever | |
| Hughes et al. | Studies on dimethyl tubocurarine in anaesthetized man | |
| US4613588A (en) | Benzaldehyde and 4,6-O-benzylidene-D-glucose for alleviating pain | |
| CN1102853C (en) | Tumor metastasis-suppressing agent and veterinary tumor metastasis-suppressing agent | |
| Türker et al. | High degree of conversion of angiotensin I to angiotensin II in the mesenteric circulation of the isolated perfused terminal ileum of the cat | |
| Jonderko et al. | Calcitonin suppresses gastric emptying of a radiolabelled solid meal in humans. | |
| CH680571A5 (en) | ||
| CA1107647A (en) | Stable secretin composition, process for its preparation and its use | |
| Tobia et al. | Renal vasodilator responses to captopril in dogs pretreated with indomethacin | |
| Christiansen et al. | Effect of endogenous and exogenous glucagon on pentagastrin-stimulated lower esophageal sphincter pressure in man |